Pluristem’s potential new breakthrough
Haifa company weeks away from presenting clinical trial results that could ‘generate hope’ for patients suffering from untreatable vascular disease.
Biologists work in a laboratory at Pluristem Therapeutics Inc. in Haifa(photo credit: BAZ RATNER/REUTERS)